Product information, investigational brochure. Richmond, VA: A. H. Robins, June, 1978: A-1-I-1.
2.
Product information. Richmond, VA: A. H. Robins, December, 1978.
3.
PinderRMBrogdenRNSawyerPRSpeightTMAveryGS, Metoclopramide: A review of its pharmacological properties and clinical use. Drugs1976; 12: 81–131.
4.
JohnsonAG, The effect of metoclopramide on gastroduodenal and gallbladder contractions. Gut1971; 12: 158–63.
5.
JacobyHIBrodieDA, Gastrointestinal actions of metoclopramide: An experimental study. Gastroenterology1967; 52: 676–84.
6.
BaumannHWMcCallumRWSturdevantRAL, Metoclopramide: A possible antagonist of dopamine in the esophagus of man. Gastroenterology1976; 70: 862.
7.
ThornerMO, Dopamine is an important neurotransmitter in the autonomic nervous system. Lancet1975; 1: 662–5.
8.
CohenSDiMarinoAJ, Mechanism of action of metoclopramide on opossum lower esophageal sphincter muscle. Gastroenterology1976; 71: 996–8.
9.
HancockBDBowen-JonesEDixonRDymockIWCowleyDJ, The effect of metoclopramide on gastric emptying of solid meals. Gut1974; 15: 462–7.
10.
EisnerM.Effect of metoclopramide on gastrointestinal motility in man: A manometric study. Digestive Diseases1971; 16: 409–19.
11.
JohnsonAG, Gastroduodenal motility and synchronization. Postgrad Med J1973; 49 (suppl 4): 29–33.
12.
EisnerM.Gastrointestinal effects of metoclopramide in man. In vitro experiments with human smooth muscle preparations. Br Med J1968; 4: 679–80.
13.
HayAM, The mechanism of action of metoclopramide. Gut1975; 16: 403.
14.
JuddSJLazarusLSmytheG.Prolactin secretion by metoclopramide in man. J Clin Endocrinol Metab1976; 43: 313–7.
15.
StanleyMLautinARotrosenJGershonS.Antipsychotic efficacy of metoclopramide: Do DA/neuroleptic receptors mediate the action of antipsychotic drugs?IRCS Med Sci1979; 7: 322.
16.
McCallumRWKlineMMCurryNSturdevantRAL, Comparative effects of metoclopramide and bethanechol on lower esophageal sphincter pressure in reflux patients. Gastroenterology1975; 68: 1114–8.
17.
BeharJBiancaniP.Effect of oral metoclopramide on gastroesophageal reflux in the post-cibal state. Gastroenterology1976; 70: 331–5.
18.
CohenSMorrisDWSchoenHJDiMarinoAJ, The effect of oral and intravenous metoclopramide on human lower esophageal sphincter pressure. Gastroenterology1976; 70: 484–7.
19.
MetzgerWHCanoRSturdevantRAL, Effect of metoclopramide in chronic gastric retention after gastric surgery. Gastroenterology1976; 71: 30–2.
20.
McClellandRNHortonJW, Relief of acute, persistent post-vagotomy atony by metoclopramide. Ann Surg1978; 188: 439–47.
21.
JamesWBHumeR.Action of metoclopramide on gastric emptying and small bowel transit time. Gut1968; 9: 203–5.
22.
PearsonMCEdwardsDTateAGilkesRSaxtonHMHowlandC.Comparison of the effects of oral and intravenous metoclopramide on the small bowel. Postgrad Med J1973; 49 (suppl 4): 47–50.
23.
KatevuoKKantoJPhilajamakiK.The effect of metoclopramide on the contraction of the human gallbladder. Invest Radio1975; 10: 197–9.
24.
KleinRLMilitelloTEBallingerCM, Antiemetic effect of metoclopramide: Evaluation in humans. Anesth Analg1968; 47: 259–64.
25.
DobkinABEversWIsraelJS, Double-blind evaluation of metoclopramide (MK 745, Sinemet®) trimethobenzamide (Tigan®) and a placebo as postanaesthetic antiemetics following methoxyflurane anaesthesia. Can Anaes Soc J1968; 15: 80–91.
26.
CannonJG, Chemistry of dopaminergic agonists. Adv Neurol1975; 9: 177–83.
27.
DolphinAJennerPMarsdenCDPycockCTarsyD.Pharmacological evidence for cerebral dopamine receptor blockade by Metoclopramide in rodents. Psychopharmacologia1975; 41: 133–8.
28.
TarsyDParkesJDMarsdenCD, Metoclopramide and pimozide in Parkinson's disease and levodopa-induced dyskinesias. J Neurol Neurosurg Psychiatry1975; 38: 331–5.
29.
ThorburnCWSowtonE.The haemodynamic effects of metoclopramide. Postgrad Med J1973; 49 (suppl 4): 22–4.
ShaklaiMPinkhasJDeVriesA.Metoclopramide and cardiac arrhythmia. Br Med J1974; 2: 385.
32.
BatemanDNKahnCMashiterKDaviesDS, Pharmacokinetic and concentration-effect studies with intravenous metoclopramide. Br J Clin Pharmacol1978; 6: 401–7.
33.
CaralpsA.Metoclopramide and renal failure. Lancet1979; 1: 554.
34.
BatemanDNDaviesDS, Pharmacokinetics of metoclopramide. Lancet1979; 1: 166.
35.
GuelrudM.Effect of intravenous metoclopramide on the incompetent lower esophageal sphincter. Am J Gastroenterol1979; 61: 119–24.
36.
ClarkeRSJDundeeJW, Side effects of anti-emetics: Results of a class experiment. Eur J Pharmacol1971; 14: 291–300.
37.
TornettaFJ, Clinical studies with the new antiemetic, metoclopramide. Anesth Analg1969; 48: 198–204.
38.
DundeeJWClarkeRSJHowardPJ, Studies of drugs given before anesthesia XXIII: Metoclopramide. Br J Anaesth1974; 46: 509–13.
39.
RobinsonOPW, Metoclopramide — Side effects and safety. Postgrad Med J1973; 49 (suppl 4): 77–80.
40.
ChristieDLAmentME, A double blind crossover study of metoclopramide versus placebo for facilitating passage of multipurpose biopsy tube. Gastroenterology1976; 71: 726–8.
41.
LavySMelamedEPenchasS.Tardive dyskinesia associated with metoclopramide. Br Med J1978; 1: 77–8.
42.
KatariaMTraubMMarsdenCD, Extrapyramidal side effects of metoclopramide. Lancet1978; 2: 1254–5.
43.
BatemanDNKahnCLeggNJReidDM, Metoclopramide in Parkinson's disease. Clin Pharmacol Ther1978; 24: 459–64.
44.
McNeillyASThornerMOVolansGBesserGM, Metoclopramide and prolactin. Br Med J1974; 2: 729.
45.
SowersJBMcCallumRWHershmanJMCarlsonHESturdevantRALMeyerN.Comparison of metoclopramide with other dynamic tests of prolactin secretion. J Clin Endocrinol Metab1976; 13: 679–81.
46.
NorbiatoGBevilacquaMRaggiU, Effect of metoclopramide, a dopaminergic inhibitor, on renin and aldosterone in idiopathic edema: Possible therapeutic approach with levodopa and carbidopa. J Clin Endocrinol Metab1979; 48: 37–42.
47.
JohnsonBFO'GradyJByeC.The influence of digoxin particle size on absorption of digoxin and the effect of propantheline and metoclopramide. Br J Clin Pharmacol1978; 5: 465–7.
48.
MearrickPTWadeDNBirkettDJMorrisJ.Metoclopramide gastric emptying and l-dopa absorption. Aust NZ J Med1974; 4: 144–8.
